DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Sunday 31 July 2016

Darryl Kato



Darryl Kato works on a hepatitis treatment at Gilead Sciences Inc.’s lab



Darryl Kato

Sr Research Scientist at Gilead Sciences

links

https://www.facebook.com/darryl.kato

https://www.linkedin.com/in/darryl-kato-31560724
https://instagy.com/user/derrold

Experience

Sr Research Scientist

Gilead Sciences
 – Present (2 years 6 months)Foster City

Education

Harvard University

PhD, Chemistry





09338-acsnews1-gileadcxd
SAVING LIVES
The Gilead team responsible for Harvoni: Front row, from left: John Link, Chris Yang, Rowchanak Pakdaman, Bob Scott, and Benjamin Graetz. Back row, from left: Erik Mogalian and Bruce Ross. Not pictured: Michael Sofia.
Credit: Gilead Sciences
Gilead’s Harvoni is a combination of two antiviral agents, sofosbuvir and ledipasvir. “In hepatitis C, the virus mutates so rapidly that to overcome resistance, we use a combination of drugs, and each one pulls their own weight in the process,” says John Link, who discovered ledipasvir.
Link says that the amount of interdisciplinary collaboration on the drug was unprecedented for the company. “Once ledipasvir was discovered, the process chemists were right there with us understanding the kinds of things we were doing, and medicinal chemists and process chemists worked on making material to scale for preclinical studies,” he says. “We all realized this was our moment to make a difference for patients with hepatitis C.”
Harvoni is the first once-a-day pill for treatment of chronic hepatitis C, and it has a cure rate in the U.S. of 94-99%. The drug is an alternative to injected interferon treatment, which has been associated with significant side effects.
“The high cure rates that we saw in our clinical trials are really amazing,” Link says. “Before we had these compounds, I had only hoped that we could equal something like interferon-type regimens in cure rates, without all the horrible side effects. To dramatically exceed them is important for patients.”
Harvoni patients can attest to the drug’s effectiveness. Mark Melancon, who had contracted hepatitis C 25 years ago, says that after taking Harvoni, he now has no trace of the virus in his body, and his liver is beginning to repair itself. “Four weeks into it, and the virus was gone. Not detectable,” he says. “To have this virus hanging over my head for 25 years and then it was just gone, I can’t explain the feeling. The people who worked hard on this medication, they need to know that I appreciate it.”
Print

str1










/////////

2 comments:

  1. We are a top internet site where you can buy best quality medications for Hepatitis C we all know hepatitis medications are expensive but you can buy them at discounted prices at our online pharmacy
    Buy Harvoni, Mavyret, vosevi, epclusa, solvadi without prescription
    Delivery is fast and guaranteed no matter your location
    Buy cheap Harvoni online at http://www.medicinepurchase.com
    Buy Harvoni online by calling +1540- 416-1464

    ReplyDelete
  2. We are a reputable online site for hepatitis c medications .Vosevi is a type of medication called a direct-acting antiviral. It contains three active drug ingredients: sofosbuvir, velpatasvir, and voxilaprevir.
    Save up on Vosevi by buying it at a cheaper rate online at our pharmacy .Buy Vosevi medication at www.medicinepurchase.com

    ReplyDelete